Drugnet Europe 88

In this issue: Lisbon Addictions 2015: call for abstracts | Best practice: from guidelines to quality standards | Financing drug policy in Europe in the wake of the economic recession | Preventing opioid deaths — legal issues around the provision of naloxone | New EMCDDA products and services